title: Bivariate random-effects meta-analysis and the estimation of between-study correlation.
abstract: BACKGROUND
  When multiple endpoints are of interest in evidence synthesis, a multivariate meta-analysis can jointly synthesise those endpoints and utilise their correlation. A multivariate random-effects meta-analysis must incorporate and estimate the between-study correlation (rhoB).
  
  
  METHODS
  In this paper we assess maximum likelihood estimation of a general normal model and a generalised model for bivariate random-effects meta-analysis (BRMA). We consider two applied examples, one involving a diagnostic marker and the other a surrogate outcome. These motivate a simulation study where estimation properties from BRMA are compared with those from two separate univariate random-effects meta-analyses (URMAs), the traditional approach.
  
  
  RESULTS
  The normal BRMA model estimates rhoB as -1 in both applied examples. Analytically we show this is due to the maximum likelihood estimator sensibly truncating the between-study covariance matrix on the boundary of its parameter space. Our simulations reveal this commonly occurs when the number of studies is small or the within-study variation is relatively large; it also causes upwardly biased between-study variance estimates, which are inflated to compensate for the restriction on rhoB. Importantly, this does not induce any systematic bias in the pooled estimates and produces conservative standard errors and mean-square errors. Furthermore, the normal BRMA is preferable to two normal URMAs; the mean-square error and standard error of pooled estimates is generally smaller in the BRMA, especially given data missing at random. For meta-analysis of proportions we then show that a generalised BRMA model is better still. This correctly uses a binomial rather than normal distribution, and produces better estimates than the normal BRMA and also two generalised URMAs; however the model may sometimes not converge due to difficulties estimating rhoB.
  
  
  CONCLUSIONS
  A BRMA model offers numerous advantages over separate univariate synthesises; this paper highlights some of these benefits in both a normal and generalised modelling framework, and examines the estimation of between-study correlation to aid practitioners.
authors.affiliation: Centre for Medical Statistics and Health Evaluation, School of Health Sciences, University of Liverpool, Shelley's Cottage, Brownlow Street, Liverpool, L69 3GS, UK. richard.riley@liv.ac.uk
authors.forename: Richard D
authors.initials: RD
authors.lastname: Riley
authors.forename: Keith R
authors.initials: KR
authors.lastname: Abrams
authors.forename: Alexander J
authors.initials: AJ
authors.lastname: Sutton
authors.forename: Paul C
authors.initials: PC
authors.lastname: Lambert
authors.forename: John R
authors.initials: JR
authors.lastname: Thompson
mesh_terms: D018791:CD4 Lymphocyte Count; D003198:Computer Simulation; D006801:Humans; D015201:Meta-Analysis as Topic; D008957:Models, Genetic; D008962:Models, Theoretical; D011897:Random Allocation; D012680:Sensitivity and Specificity; D019098:Telomerase / Q000235:genetics*
chemical_list: D019098:Telomerase